Rainbow Children's Medicare Q1 FY27 Revenue Surges 33% YoY to ₹470 Crore; Expands to Mumbai
Rainbow Children's Medicare reported Q1 FY27 revenue of ₹470 crore, up 33% YoY. EBITDA stood at ₹134.6 crore with a 28.6% margin. The company is expanding to Mumbai with a 100-bed hospital and acquiring hospitals in Nellore and Guntur, Andhra Pradesh.
The announcement includes significant financial growth, strategic expansion into a major metro city (Mumbai), and acquisitions in a key state (Andhra Pradesh), which are material developments for the company.
The company reported strong year-on-year revenue growth, improved operational metrics, and strategic expansion plans, indicating positive performance and future outlook.
Rainbow Children's Medicare Limited (RCML) announced its un-audited financial results for the quarter ended June 30, 2026, showcasing a robust performance with a year-on-year revenue growth of approximately 33%. This growth was driven by strong patient demand and contributions from both mature and newly commissioned hospitals. The company reported a healthy EBITDA margin of approximately 29%.
Key operational metrics also saw significant increases, with inpatient admissions growing by 28%, outpatient consultations by 25%, and deliveries by 23%. The company's new hospitals commissioned over the past year are performing well and meeting expectations.
Strategically, Rainbow is set to enter the Mumbai market with a 100-bed brownfield hospital in Malad, expected to commence operations in Q1 FY28. This expansion marks a significant milestone, establishing its presence in Western India. Furthermore, RCML is strengthening its footprint in Andhra Pradesh through the acquisition of a 70-bed children’s hospital in Nellore and a 50-bed hospital in Guntur.
The company also provided updates on its ongoing projects: the Indore hospital is on track for Q3 FY27 operations, Coimbatore and Gurugram (Sector 56) are targeted for Q3 FY28, Gurugram (Sector 44) for Q1 FY29, and Pune and Seegehalli (Bengaluru) for FY29. Rainbow maintains a strong balance sheet with cash and equivalents totaling ₹612.9 crore as of June 30, 2026, sufficient to fund its expansion plans.
Dr. Ramesh Kancharla, Chairman & Managing Director, expressed confidence in the company's growth momentum and its ability to reach more families with specialized care, particularly highlighting the significant long-term opportunity in Mumbai. Mr. Abarali Dalal, CEO, emphasized the strong execution, healthy patient volumes, and sustained EBITDA margins, while outlining a focus on operational excellence and digital transformation.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.